XERS

Xeris Biopharma Holdings, Inc. $10.64 as of 2026-10-28
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
-0.0%
Next 1 week
+0.9%
Next 1 month
+2.4%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 78
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.26%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.86 +2.2% · Seasonal tilt (7y) +0.1%
$24M/day volume 54% volatility +14% 1-year -62% from ATH
52-week range · 87% of the way up · -7% from the high
$5.25$11.42

Earnings Full history →

Next report 2026-11-05 (Thursday, before open, in 7 days) · EPS est. 0.03.

1-day std dev
11.5%
Finished up
58%
Biggest pop
+20.2%
Biggest drop
-21.9%

Standard deviation of the close-to-close move over the last 19 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-06 miss — — -172.0% -11.3% -9.2% +2.7%
2026-05-07 beat — 0.01 +1592.5% +5.2% +4.1% +0.2%
2026-03-02 beat 0.05 0.06 +33.3% +15.7% -1.6% -8.5%
2025-11-06 miss — — -100.0% -14.9% -21.9% -26.4%
2025-08-07 beat -0.03 -0.01 +66.7% +22.6% +20.2% +33.0%
2025-05-08 miss -0.04 -0.06 -50.0% -0.2% +15.2% +6.9%
2025-03-06 miss -0.02 -0.03 -50.0% +9.8% +9.5% +21.0%
2024-11-08 beat -0.08 -0.06 +21.1% +1.2% +3.3% -13.1%
2024-08-08 miss -0.09 -0.10 -6.4% +5.2% +4.7% +23.0%
2024-05-09 miss -0.11 -0.14 -32.1% +0.0% +1.6% +9.2%
2024-03-06 miss -0.09 -0.10 -16.3% -1.3% -19.5% -29.2%
2023-11-09 beat -0.10 -0.09 +14.3% +4.5% -8.6% -20.7%
2023-08-08 miss -0.11 -0.14 -27.3% -2.8% +3.6% -10.4%
2023-05-09 beat -0.15 -0.12 +21.7% +2.1% +13.7% +18.8%
2023-03-08 beat -0.15 -0.10 +33.3% -1.3% -11.8% -15.0%
2022-11-09 miss -0.15 -0.16 -3.2% +8.0% -1.3% -10.7%
2022-08-10 beat -0.22 -0.19 +12.3% +1.8% +13.5% +8.8%
2022-05-11 miss -0.24 -0.25 -4.2% +3.9% -8.4% +22.3%
2022-03-11 miss -0.17 -0.44 -164.0% -2.3% +3.1% +5.7%

Not investment advice.